Insulin biosimilar wins first-ever interchangeable designation from FDA
For the first time ever, the FDA on Wednesday green-lighted an interchangeable biosimilar, capping a decade-long quest for such an approval since the pathway was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
